Inhibition '/>
机译:临床候选IDH305的发现与评估,脑渗透突变体IDH1抑制剂
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
Novartis Institutes for BioMedical Research 250 Massachusetts Avenue Cambridge Massachusetts 02139 United States;
brain penetration; clinical candidate; in vivo anticancer activity; inhibition of 2-HG production; Mutant IDH1;
机译:临床候选IDH305的发现与评估,脑渗透突变体IDH1抑制剂
机译:vorasidenib(AG-881):突变体IDH1和2的一类级,脑渗透双抑制剂,用于治疗胶质瘤
机译:优化3-嘧啶-4-基氧唑烷-2-口服生物可利用和脑渗透突变体IDH1抑制剂的优化
机译:通过非变性质谱法定量基质和抑制剂与野生型和突变体相酯脱氢酶(IDH1)的结合
机译:腐蚀抑制渗透剂后张紧肌腱中灌浆粘接到灌浆键的评价
机译:临床候选者IDH305的发现和评估脑渗透突变IDH1抑制剂
机译:临床候选IDH305的发现和评估,脑渗透突变体IDH1抑制剂